Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |